Medical Technology

@xconomy.com 4 years ago

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

@xconomy.com 4 years ago

Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More

@xconomy.com 4 years ago

Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More

@xconomy.com 4 years ago

Review: Inside the House of Lies at Theranos

@xconomy.com 5 years ago

Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More

@xconomy.com 5 years ago

Hatteras Launches New Fund With $94M for Life Science Investments

@xconomy.com 5 years ago

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

@xconomy.com 5 years ago

Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More

@xconomy.com 5 years ago

Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More

@xconomy.com 5 years ago

In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect